Geldanamycin

Catalog No.S2713 Synonyms: NSC 122750

Geldanamycin Chemical Structure

Molecular Weight(MW): 560.64

Geldanamycin is a natural existing HSP90 inhibitor with Kd of 1.2 μM, specifically disrupts glucocorticoid receptor (GR)/HSP association.

Size Price Stock Quantity  
USD 170 In stock
USD 270 In stock
USD 670 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

3 Customer Reviews

  • Phenotypic effect of Genetic or Pharmacologic Compromise of the 477 Hsp70-StiA-Hsp90 Complex. The impact of each genetic modification on radial growth, conidiation, and response to various stress conditions was assessed after inoculation of a suspension of 104 conidia on glucose minimal medium (GMM) agar plates and incubation at 37ºC for 5 days.

    Antimicrob Agents Chemother, 2015, 10.1128/AAC.00946-15. Geldanamycin purchased from Selleck.

    C2C12 myoblasts were transfected with HA-tagged A17-PABPN1 constructs. Twenty-four hours post-transfection, cells were treated with CHX (10 μg/ml) alone or together with geldanamycin (2.5 μM) for the indicated times at 37°C. Lysates were blotted to show the expression of the proteins of interest. Band density was quantified and is shown in the line graph (right panels). Data are shown as the mean ± SEM (n = 5); **, P < 0.01.

    PLoS One, 2015, 10(9):e0138936.. Geldanamycin purchased from Selleck.

  • RT-qPCR analysis of eNOS mRNA and representative Western blot images of eNOS expression, respectively, in irradiated BAECs pretreated of geldanamycin (GA; 500 nM). At 12 h after 10 Gy irradiation, BAECs were harvested. The results suggest that both HSP90 is involved in the upregulation of eNOS in irradiated BAECs.

    Radiat Res, 2018, 189(5):519-528. Geldanamycin purchased from Selleck.

Purity & Quality Control

Choose Selective HSP (e.g. HSP90) Inhibitors

Biological Activity

Description Geldanamycin is a natural existing HSP90 inhibitor with Kd of 1.2 μM, specifically disrupts glucocorticoid receptor (GR)/HSP association.
Targets
p185 [4]
(SKBr3 cells)
HSP90 (N-terminal domain) [1]
(Cell-free assay)
HSP90 [1]
(Cell-free assay)
70 nM 0.78 μM(Kd) 1.2 μM(Kd)
In vitro

Geldanamycin binds in the ATP-binding site in the N-terminus domain of Hsp90s (residues 1-220). Geldanamycin inhibits the ATPase activity of Hsp90 in a dose-dependent manner. [1] Geldanamycin causes a dose-dependent G2 arrest and reversible inhibiton o f entry into the S phase in A2780 human ovarian cell line. This inhibition is accompanied by p53 increase and finally demonstrated to be p53 dependent. [2] Geldanamycin causes polyubiquitination and proteasomal degradation of the p185 receptor protein-tyrosin kinase and shows a IC50 with 70 nM. [3, 4] Geldanamycin is a typical anti-tumor reagent, shows a mean GI50 with 0.18 μM against the panel of 60 human tumor cell lines. [5]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
A2780 cells MYnQdo9tcW[ncnH0bY9vKGG|c3H5 NEi3NHJEd22yb4Xu[EB4[XNiZY\hcJVifGWmIH\vdkBidnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIH;2ZZJq[W5iY3HyZ4lvd22jIHPlcIwhdGmwZTDBNlc5OCxiSVO1NF0{NjRizszN Mlz6NVE2OTRzNEW=
SW620 cell NVPIWJFIT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= Mo\NTY5pcWKrdH;yfUBkd26lZX70doF1cW:wIHHnZYlve3RiaIXtZY4h[2:ub4LlZ5RidCClYYLjbY5wdWFiU2e2NlAh[2WubDDsbY5meyxiSVO1NF03NjJibl2= NWfDXnprOTV4NUi4O|k>
MCF-7 cell NWDxdldmT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MUfJcohq[mm2b4L5JINwdmOnboTyZZRqd25iYXfhbY5{fCCqdX3hckBjemWjc4SgZ4Fv[2W{IF3DSk04KGOnbHygcIlv\XNuIFnDOVA:Pi53IH7N NI\TeGEyPTZ3OEi3PS=>
SKBR3 cells MXrQdo9tcW[ncnH0bY9vKGG|c3H5 NUDyepR[PzJiaB?= NFLKUGJCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIV{fHKxZ3XuJJJm[2WydH;yJIRm\mmlaXXueEBpfW2jbjDTT2JTOyClZXzsd{Bi\nSncjC3NkBpenNuIFnDOVA:QC53IH7N NEjES|kzOzZ2OEG4NC=>
MCF7 cells NX;rUGtCWHKxbHnm[ZJifGmxbjDhd5NigQ>? M{DNRVczKGh? NXu1UWNtSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNR2Y4KGOnbHzzJIV5eHKnc4Ppcoch\XO2cn;n[Y4hemWlZYD0c5Ih[W[2ZYKgO|IhcHK|LDDJR|UxRTlwODDuUS=> MUGyN|Y1QDF6MB?=
MDA-kb2 cells M{e4UGZ2dmO2aX;uJIF{e2G7 NYP6NnhlOThiaB?= MoPSTY5pcWKrdHnvckBw\iCKU2C5NEBqdiCqdX3hckBOTEFva3KyJINmdGy|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiCpbIXjc4NwenSrY3;p[EBz\WOncITvdk1l\XCnbnTlcpQhdHWlaX\ldoF{\SCneIDy[ZN{cW:wIHHmeIVzKDF6IHjyd{BjgSCoaYLl[ox6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygTWM2OD1zMDDuUS=> MXeyOFk5PDl|Nh?=
human SK-BR-3 cells M3vzVXBzd2yrZnXyZZRqd25iYYPzZZk> NEHKc4xCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGPLMWJTNTNiY3XscJMtKEmFNUC9NVUvQCCwTR?= M3jBTFE6QDl4OES4
HUVEC cells Mn7DR5l1d3SxeHnjxsBie3OjeR?= NGjYXpg4OiCq MoHOR5l1d3SxeHnjbZR6KGGpYXnud5QhUFWYRVOgZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NF0yQSCwTR?= NHvw[WozPTJ5N{C2Oy=>
human HCT116 cells Mnf0S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NYTnN|NoT3Kxd4ToJIlvcGmkaYTpc44hd2ZiaIXtZY4hUEOWMUG2JINmdGy|LDDHTVUxRTJzIH7N Mmf4NVgzPDN5MEO=
K562 cell MkT3S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MVHJcohq[mm2b4L5JINwdmOnboTyZZRqd25iYXfhbY5{fCCqdX3hckBt\XWtZX3pZUBMPTZ{IHPlcIwhdGmwZYOsJGlEPTB;MkKuNUBvVQ>? M{LwVVE2PjV6OEe5
HT-29 cell M1TrVWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MnjrTY5pcWKrdH;yfUBkd26lZX70doF1cW:wIHHnZYlve3RiaIXtZY4h[2:ub4LlZ5RidCClYYLjbY5wdWFiSGStNlkh[2WubDDsbY5meyxiSVO1NF0zPC53IH7N NFfP[48yPTZ3OEi3PS=>
HCT116 cells M4nGRnBzd2yrZnXyZZRqd25iYYPzZZk> MnLmRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCKQ2SxNVYh[2WubIOgZpkhdHWvaX7ld4NmdmOnIHHzd4F6NCCHQ{WwQVAvODNizszN NH3CdXMzOTZyNUm3OS=>
NCI-H1975 cells NIHUPJZRem:uaX\ldoF1cW:wIHHzd4F6 MYPBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE6FST3INVk4PSClZXzsd{whUUN3ME2zOkBvVQ>? Mlf4NlE4OTVzNkW=
human DLD1 cells NUT0WZpVT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MYPHdo94fGhiaX7obYJqfGmxbjDv[kBpfW2jbjDEUGQyKGOnbHzzMEBIUTVyPUO3JI5O M2rMXVE5OjR|N{Cz
human A431 cells MUTDfZRwfG:6aXRCpIF{e2G7 M3;iWlczKGh? M1vLOGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGE1OzFiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3ME20NEBvVQ>? M1ftZVI2Ojd5ME[3
human HepG2 cells MVTDfZRwfG:6aXRCpIF{e2G7 NGr3NXQ4OiCq NHjXUlNEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJ\XCJMjDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVQxKG6P MV6yOVI4PzB4Nx?=
human BGC823 cells NF75XFZEgXSxdH;4bYPDqGG|c3H5 NX71XXE3PzJiaB?= MlrBR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRmdEQDJ|IHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUC9OFAhdk1? M132VVI2Ojd5ME[3
human SKBR3 cells NV3s[nBXS3m2b4TvfIlkyqCjc4PhfS=> NIDCdXQ4OiCq M2\sTmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHNMSlJ|IHPlcIx{KGGodHXyJFczKGi{czDifUBk\WyudHn0[ZIu\2yxIHHzd4F6NCCLQ{WwQVQyKG6P MnrENVk1ODV3Mki=
human MDA-MB-231 cells NVnmfGVMS3m2b4TvfIlkyqCjc4PhfS=> MlT4O|IhcA>? MV;DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNSGEuVUJvMkOxJINmdGy|IHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVA:PTBibl2= MoDzNlUzPzdyNke=
human A549 cells Ml7HS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? M2mxVWdzd3e2aDDpcohq[mm2aX;uJI9nKGi3bXHuJGE2PDliY3XscJMtKEeLNUC9OlQhdk1? MkLYNVgzPDN5MEO=
Sf9 cells Mlf3SpVv[3Srb36gZZN{[Xl? M{DZVGRqe3CuYXPlcYVvfCCxZjDHUU1DV0SLUGmg[pJwdSCqdX3hckBnfWyuIHzlcod1cCCKU2C5NEBidHCqYTDlfJBz\XO|ZXSgbY4h[mGldXzveolzfXNvaX7m[YN1\WRiU3[5JINmdGy|IHHmeIVzKDF4IHjyd{BjgSCobIXvdoV{[2WwY3WgdI9t[XKrenH0bY9vKGG|c3H5MEBKSzVyPUe0JI5O M3;NbFI1PzVzNESx
human U87MG cells M3XUNXBzd2yrZnXyZZRqd25iYYPzZZk> MY\BcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFV6N13HJINmdGy|LDDJR|UxRTh7IH7N MoXBNlE4OTVzNkW=
human A549 cells M2XjW2N6fG:2b4jpZ:Kh[XO|YYm= MmHWO|IhcA>? NV\GWpdnS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hSTV2OTDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVk4KG6P MViyOVI4PzB4Nx?=
mouse P19 cells MXHDfZRwfG:6aXRCpIF{e2G7 NHXRbpUyQCCq M{Xs[2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KG2xdYPlJHAyQSClZXzsd{Bi\nSncjCxPEBpenNuIFnDOVA:OC5zIN88US=> NWXJSFQ2OTd2NEK1OlU>
human HL7702 cells NVvldGFWS3m2b4TvfIlkyqCjc4PhfS=> MX63NkBp MY\DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDIUFc4ODJiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3ME2wMlE1OSEQvF2= M1nBRlI2Ojd5ME[3
human A549 cells M3ToUmN6fG:2b4jpZ:Kh[XO|YYm= M1jF[FIh\GG7cx?= NUPEU4JFS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hSTV2OTDj[YxteyCjZoTldkAzKGSjeYOgZpkhSWyjbXHyRox2\SCjc4PhfUwhUUN3ME2wMlE2KM7:TR?= Mmr4NlM6PDd5OUS=
human A431 cells MYXQdo9tcW[ncnH0bY9vKGG|c3H5 NIS2TWE4OiCq NYDWV5RrSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDBOFMyKGOnbHzzJIFnfGW{IEeyJIhzeyxiSVO1NF0xNjJizszN NWPFTHVwOjB4NUWyN|c>
human HepG2 cells NH;kOGNEgXSxdH;4bYPDqGG|c3H5 NXjQVJdLS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUGWyR{KgZ4VtdHNiYomgUXRVKGG|c3H5MEBKSzVyPUCuN{DPxE1? MWOyN|Y2PjV3Nh?=
human SW480 cells M1S3[mN6fG:2b4jpZ:Kh[XO|YYm= M3KyflczKGh? NIHwbpdEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBUXzR6MDDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVAvOzFizszN MYKyOVI4PzB4Nx?=
human LNCAP cells Ml;iR5l1d3SxeHnjxsBie3OjeR?= NWDLUHcxPzJiaB?= NV[zfWRUS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVE6FQWCgZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NF0xNjR|IN88US=> MWGyOVExPTl{NB?=
human LS174T cells NXXPXZpOS3m2b4TvfIlkyqCjc4PhfS=> Mki3R5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUHMyPzSWIHPlcIx{KGK7IF3UV{Bie3OjeTygTWM2OD1yLkS1JO69VQ>? NEf3SYYyPzB|NEGzOS=>
human HeLa cells MU\DfZRwfG:6aXRCpIF{e2G7 MkTYO|IhcA>? NH7MPWFEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJ\UyjIHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUC9NE44QThizszN MYqyOVI4PzB4Nx?=
rat L6 cells Mo\FR5l1d3SxeHnjxsBie3OjeR?= M3vU[FczKGh? NFT6fnREgXSxdH;4bYNqfHliYXfhbY5{fCC{YYSgUFYh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IFHsZY1ieiCEbIXlJIF{e2G7LDDJR|UxRTVizszN MXGyOFU5ODV|MR?=
human MCF7 cells MnvaR5l1d3SxeHnjxsBie3OjeR?= M2\6fmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJG1ETjdiY3XscJMh[nliU2LCJIF{e2G7LDDJR|UxRTlwNjFOwG0> MkewNVk2PjB|NUO=
human MCF7 cells MkLWS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? M1fzSGdzd3e2aDDpcohq[mm2aX;uJI9nKGi3bXHuJG1ETjdiY3XscJMh[W[2ZYKg[IF6eyCkeTDTVmIh[XO|YYmsJGdKPTB;M{WuOkDPxE1? NUHzWW5YOTd6NkmwPVg>
HEK293T cells NFLyNHpHfW6ldHnvckBie3OjeR?= MVLJcohq[mm2aX;uJI9nKFSQRj3hcJBp[S2rbnT1Z4VlKE6ILXvhdJBiSiCjY4TpeoF1cW:wIHX4dJJme3OnZDDpckBJTUt{OUPUJINmdGy|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigQ>? NIPTfmcyQDRyOEexNy=>
human Jurkat cells NIm2R4VHfW6ldHnvckBie3OjeR?= Mm\4TY5pcWKrdHnvckBw\iCWTl[tZYxxcGFvaX7keYNm\CCQRj3rZZBx[UJiYXP0bZZifGmxbjDlfJBz\XO|ZXSgbY4hTkGGRDDk[YZq[2mnboSgbJVu[W5iSoXyb4F1KGOnbHzzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeR?= M4PTZlE5PDB6N{Gz
human SKBR3 cells M4XzR2Z2dmO2aX;uJIF{e2G7 M1;zNFI1KGh? NUnjdHV2UW6qaXLpeIlwdiCxZjDId5A6OC2vZXTpZZRm\CCKRWKyJIRm\3KjZHH0bY9vKGmwIHj1cYFvKFONQmKzJINmdGy|IHHmeIVzKDJ2IHjyd{BjgSCZZYP0[ZJvKGKub4S= M3f0flE5QDF4MUGx

... Click to View More Cell Line Experimental Data

In vivo Geldanamycin (50 mg//kg) shows 30% inhibition on pl85-associated phosphotyrosine levels in FRE/erbB-2 mice. [6]

Protocol

Kinase Assay:

[1]

+ Expand

Isothermal Titration Calorimetry (ITC) of Nucelotide Binding:

The titration experiments are performed using the MSC system. In each experiment, 16 aliquots of 15 μL of geldanamycin (300 μM in 1% DMSO) are injected into 1.3 mL of protein (31 μM in 20 mMTris-HCl, pH 7.5, 1 mMEDTA) at 25 °C, and the resulting data are fit after subtracting the heats of dilution. Heats of dilution are determined in separate experiments from addition of geldanamycin into buffer and buffer into protein. No evidence for binding of DMSO in the nucleotide binding site is observed. Titration data are fit using a nonlinear least-squares curve-fitting algorithm with three floating variables: stoichiometry, binding constant (Kb) 1/Kd), and change of enthalpy of interaction (ΔH°). Dissociation constants estimated for geldanamycin binding to intact yeast Hsp90 is 1.22 μM, and for binding to Hsp90 N-terminal domain is 0.78 μM. No meaningful heat is observed with binding to the C-terminal fragment.
Cell Research:

[2]

+ Expand
  • Cell lines: A2780 human ovarian cell line
  • Concentrations: 0.001-10 μM
  • Incubation Time: 3 hours
  • Method:

    Exponentially growing cells are treated with Geldanamycin and at various times DNA synthesis is assessed by incorporation of bromodeoxyuridine (BrdUrd) and flow cytometric analysis. No marked difference in total cell number is noted during this time course for treated and untreated cultures. BrdUrd (10 μM) is incorporated over a 4-h incubation period at 37 °C and cells are harvested and fixed in 70% ethanol. After denaturation of the DNA with 2 N HC1, cells are incubated with an anti-BrdUrd mouse monoclonal antibody followed by a fluorescein isothiocyanate (FITC)-linked goat anti-mouse IgG. Cells are stained for 30 minutes at room temperature with propidium iodide and analysed by flow cytometry using a Coulter EPICS Profile Analyzer.


    (Only for Reference)
Animal Research:

[6]

+ Expand
  • Animal Models: FRE/erbB-2 tumors in nu/nu mice
  • Formulation: Geldanamycin is dissolved in DMSO.
  • Dosages: 50 mg/kg
  • Administration: Administered via i.p.
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 36 mg/mL warmed (64.21 mM)
Water Insoluble
Ethanol Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 560.64
Formula

C29H40N2O9

CAS No. 30562-34-6
Storage powder
in solvent
Synonyms NSC 122750

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

HSP (e.g. HSP90) Signaling Pathway Map

HSP (e.g. HSP90) Inhibitors with Unique Features

Related HSP (e.g. HSP90) Products4

Tags: buy Geldanamycin | Geldanamycin supplier | purchase Geldanamycin | Geldanamycin cost | Geldanamycin manufacturer | order Geldanamycin | Geldanamycin distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID